Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 3/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5844868 | 1.00 | GPR84 (0.45) | GPR84FFAR1MAPTSMPD1FFAR4 | |
| SCHEMBL7543272 | 1.00 | GPR84 (0.45) | GPR84FFAR1MAPTSMPD1FFAR4 | |
| SCHEMBL304347 | 1.00 | GPR84 (0.45) | GPR84FFAR1MAPTSMPD1FFAR4 | |
| SCHEMBL303234 | 1.00 | GPR84 (0.45) | GPR84FFAR1MAPTSMPD1FFAR4 | |
| SCHEMBL303992 | 1.00 | GPR84 (0.45) | GPR84FFAR1MAPTSMPD1FFAR4 | |
| SCHEMBL303035 | 0.98 | GPR84 (0.42) | GPR84FFAR1MAPTSMPD1FFAR4 | |
| SCHEMBL303933 | 0.91 | — | — | |
| SCHEMBL302818 | 0.82 | — | — | |
| SCHEMBL9766360 | 0.79 | GPR84 (0.41) | GPR84FFAR1MAPTSMPD1FFAR4 | |
| SCHEMBL9766333 | 0.79 | GPR84 (0.41) | GPR84FFAR1MAPTSMPD1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9255070-B2 | Method of deuteration using mixed catalyst | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2016-02-09 | — | — | US | disclosed |
| US-8669375-B2 | Process for producing ester compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-03-11 | — | — | US | disclosed |
| US-20130066070-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-03-14 | — | — | US | disclosed |
| US-8318964-B2 | Process for producing ester compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| US-8093422-B2 | Method for deuteration of an aromatic ring | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20100324314-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
| US-7618914-B2 | Method for producing hydroxylamine compound using platinum catalyst fixed on ion-exchange resin | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2009-11-17 | — | — | US | disclosed |
| US-7517990-B2 | Method for deuteration of a heterocyclic ring | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-14 | — | — | US | disclosed |
| US-20080234488-A1 | Method of Deuteration Using Mixed Catalyst | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2008-09-25 | — | — | US | disclosed |
| US-20080145303-A1 | Method for Producing Deuterium Gas and Catalytic Deuteration Method Using Deuterium Gas Obtained Thereby | WAKO PURE CHEMICAL INDUSSRIES, LTD. (JP) | 2008-06-19 | — | — | US | disclosed |
| US-20020062012-A1 | Novel azoamidine compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2002-05-23 | — | — | US | disclosed |
| EP-1195376-A1 | Azoamidine compounds and their use as polymerization initiators | Wako Pure Chemical Industies, Ltd. (JP) | 2002-04-10 | — | — | EP | disclosed |
| EP-0939075-B1 | A novel azoamidine compound | WAKO PURE CHEM IND LTD (JP) | 2002-01-09 | — | — | EP | disclosed |
| US-6049003-A | POLYMERIZATION INITIATOR | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2000-04-11 | — | — | US | disclosed |
| US-6031084-A | Azoamide compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2000-02-29 | — | — | US | disclosed |
| EP-0779318-B1 | Silicon-containing block copolymer | WAKO PURE CHEMICAL INDUSTIES L (JP) | 2000-02-16 | — | — | EP | disclosed |
| EP-0957114-A1 | Azoamide compounds and their use as polymerisation initiators | Wako Pure Chemical Industries, Ltd. (JP) | 1999-11-17 | — | — | EP | disclosed |
| EP-0939075-A1 | A novel azoamidine compound | Wako Pure Chemical Industries, Ltd. (JP) | 1999-09-01 | — | — | EP | disclosed |
| US-5760136-A | FORMING AN ADDITION-CONDENSATION COPOLYMER BY POLYMERIZING AN AZO-CONTAINING POLYSILOXANE AND AN UNSATURATED MONOMER; CATIONIC AND NONIONIC POLYMERS; POLYAMPHOLYTES; COATINGS; ADHESIVES; PAINTS; HAIR COSMETICS | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1998-06-02 | — | — | US | disclosed |
| EP-0779318-A1 | Silicon-containing block copolymer | Wako Pure Chemical Industries, Ltd. (JP) | 1997-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130066070-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | ADH1C, ADH5, ADH1A | GPR84 1766/4885FFAR1 409/4885MAPT 1394/4885 |
| US-20080145303-A1 | Method for Producing Deuterium Gas and Catalytic Deuteration Method Using Deuterium Gas Obtained Thereby | HDHD5, IDH2, IDH1 | GPR84 2382/4885FFAR1 4263/4885MAPT 4759/4885 |
| US-20080234488-A1 | Method of Deuteration Using Mixed Catalyst | HDHD5, DHX35, HRH3 | GPR84 2786/4885FFAR1 4737/4885MAPT 4578/4885 |
| US-20100324314-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | ADH1C, ADH5, ADH1A | GPR84 1775/4885FFAR1 451/4885MAPT 1821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.